HOFFMAN ROBERT Insider Trading
Get the latest insider transactions of HOFFMAN ROBERT. HOFFMAN ROBERT is CFO & SVP, Finance in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and CFO & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and SVP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in CombiMatrix Corp ($CBMX) and CHIEF FINANCIAL OFFICER in INNOVUS PHARMACEUTICALS, INC. ($INNV) and Director in Kura Oncology, Inc. ($KURA) and Director in DelMar Pharmaceuticals, Inc. ($DMPI) and Director in Aravive, Inc. ($VSAR). Discover the current value of HOFFMAN ROBERT shares.
Address: C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE SAN DIEGO 92121CA
HOFFMAN ROBERT is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
ARNA | ARENA PHARMACEUTICALS INC | SVP, Finance and CFO, VP, Finance and CFO, CFO & CAO, VP, Finance & CAO, VP, Finance | 3,382 | 5,039.18 |
MBVX | MABVAX THERAPEUTICS HOLDINGS, INC. | 4,438 | 13,180.86 | |
KURA | Kura Oncology, Inc. | Director | 0 | 0.00 |
CBMX | CombiMatrix Corp | Director | 6,618 | 24,155.70 |
INNV | INNOVUS PHARMACEUTICALS, INC. | CHIEF FINANCIAL OFFICER | 0 | 0.00 |
HRTX | HERON THERAPEUTICS, INC. /DE/ | CFO & SVP, Finance | 1,280 | 17,088.00 |
KTRA | Kintara Therapeutics, Inc. | Director | 0 | 0.00 |
ARAV | Aravive, Inc. | Director | 0 | 0.00 |
Insider Trading Transactions of HOFFMAN ROBERT
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | KURA | Kura Oncology, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 21.54 | 23,000 | 495,420 | 23,000 |
Sep 17 2020 | DMPI | Kintara Therapeutics, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | 1.70 | 120,000 | 204,000 | 120,000 |
Jun 30 2020 | DMPI | DelMar Pharmaceuticals, I ... | HOFFMAN ROBERT | Director | Option Exercise | 0.61 | 39,567 | 24,136 | 75,000 |
Jun 26 2020 | KURA | Kura Oncology, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 17.97 | 23,000 | 413,310 | 23,000 |
Dec 23 2019 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | 25.02 | 100,000 | 2,502,000 | 100,000 |
Sep 13 2019 | ARAV | Aravive, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 5.77 | 7,500 | 43,275 | 7,500 |
Sep 09 2019 | DMPI | DelMar Pharmaceuticals, I ... | HOFFMAN ROBERT | Director | Option Exercise | 0.61 | 39,567 | 24,136 | 39,567 |
Sep 09 2019 | DMPI | DelMar Pharmaceuticals, I ... | HOFFMAN ROBERT | Director | Option Exercise | 0.61 | 35,433 | 21,614 | 35,433 |
Jun 27 2019 | KURA | Kura Oncology, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 19.55 | 13,000 | 254,150 | 13,000 |
May 01 2019 | DMPI | DelMar Pharmaceuticals, I ... | HOFFMAN ROBERT | Director | Option Exercise | 0.00 | 200,000 | 0 | 0 |
Jan 07 2019 | VSAR | Aravive, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 3.69 | 7,500 | 27,675 | 7,500 |
Jan 07 2019 | VSAR | Aravive, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 3.69 | 4,688 | 17,299 | 4,688 |
Dec 18 2018 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | 24.97 | 71,000 | 1,772,870 | 71,000 |
Nov 13 2018 | DMPI | DelMar Pharmaceuticals, I ... | HOFFMAN ROBERT | Director | Option Exercise | 0.61 | 40,000 | 24,396 | 40,000 |
Jul 03 2018 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | 13.22 | 744 | 9,834 | 1,280 |
Jul 03 2018 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | 15.30 | 30,000 | 459,000 | 31,280 |
Jul 03 2018 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Sell | 38.15 | 28,940 | 1,104,107 | 2,340 |
Jul 03 2018 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Sell | 38.80 | 1,060 | 41,123 | 1,280 |
Jul 03 2018 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | 15.30 | 30,000 | 459,000 | 100,000 |
Jun 08 2018 | KURA | Kura Oncology, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 16.35 | 13,000 | 212,550 | 13,000 |
Apr 17 2018 | DMPI | DelMar Pharmaceuticals, I ... | HOFFMAN ROBERT | Director | Option Exercise | 1.06 | 36,000 | 38,160 | 36,000 |
Apr 17 2018 | DMPI | DelMar Pharmaceuticals, I ... | HOFFMAN ROBERT | Director | Option Exercise | 0.00 | 200,000 | 0 | 200,000 |
Dec 20 2017 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | 13.05 | 536 | 6,993 | 536 |
Dec 20 2017 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | 17.00 | 56,667 | 963,339 | 56,667 |
Nov 16 2017 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Sell | 0.00 | 2,001 | 0 | 6,618 |
Nov 16 2017 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Sell | 0.00 | 6,618 | 0 | 0 |
Nov 16 2017 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Option Exercise | 46.80 | 1,619 | 75,769 | 0 |
Jun 12 2017 | KURA | Kura Oncology, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 8.60 | 10,000 | 86,000 | 10,000 |
May 23 2017 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Option Exercise | 1.80 | 50,000 | 90,000 | 50,000 | |
Apr 24 2017 | HRTX | HERON THERAPEUTICS, INC. ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | 15.30 | 130,000 | 1,989,000 | 130,000 |
Apr 04 2017 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Buy | 0.00 | 1,543 | 0 | 4,438 | |
Apr 04 2017 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Option Exercise | 0.00 | 1,543 | 0 | 1,543 | |
Jan 03 2017 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Option Exercise | 3.38 | 4,100 | 13,858 | 4,100 | |
Nov 21 2016 | INNV | INNOVUS PHARMACEUTICALS, ... | HOFFMAN ROBERT | CHIEF FINANCIAL OFFIC ... | Option Exercise | 0.00 | 2,500,000 | 0 | 2,500,000 |
Aug 30 2016 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Option Exercise | 5.00 | 4,100 | 20,500 | 4,100 | |
Jul 28 2016 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Option Exercise | 0.55 | 35,000 | 19,250 | 35,000 | |
May 13 2016 | KURA | Kura Oncology, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 3.12 | 10,000 | 31,200 | 10,000 |
May 10 2016 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Buy | 3.19 | 5,000 | 15,963 | 7,409 |
Apr 05 2016 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Buy | 0.00 | 11,417 | 0 | 21,417 | |
Apr 05 2016 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Option Exercise | 0.00 | 11,417 | 0 | 22,833 | |
Aug 27 2015 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Option Exercise | 1.52 | 35,000 | 53,200 | 35,000 | |
Apr 27 2015 | KURA | Kura Oncology, Inc. | HOFFMAN ROBERT | Director | Option Exercise | 6.32 | 30,000 | 189,600 | 30,000 |
Apr 03 2015 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Director | Option Exercise | 2.30 | 34,250 | 78,775 | 34,250 |
Apr 03 2015 | MBVX | MABVAX THERAPEUTICS HOLDI ... | HOFFMAN ROBERT | Director | Option Exercise | 0.00 | 34,250 | 0 | 34,250 |
Oct 02 2012 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | SVP, Finance and CFO | Buy | 1.48 | 50,000 | 74,000 | 53,382 |
Oct 02 2012 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | SVP, Finance and CFO | Sell | 8.32 | 50,000 | 415,980 | 3,382 |
Oct 02 2012 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | SVP, Finance and CFO | Option Exercise | 1.48 | 50,000 | 74,000 | 150,000 |
Jul 09 2012 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | SVP, Finance and CFO | Sell | 11.00 | 10,000 | 110,000 | 2,763 |
Mar 19 2012 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 1.81 | 285,000 | 515,850 | 285,000 |
Jan 10 2012 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Buy | 1.64 | 150 | 246 | 12,294 |
Jan 10 2012 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 1.63 | 150 | 245 | 12,144 |
Sep 15 2011 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 1.48 | 200,000 | 296,000 | 200,000 |
Mar 18 2010 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 3.25 | 65,000 | 211,250 | 65,000 |
Mar 18 2009 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 4.01 | 35,000 | 140,350 | 35,000 |
Sep 02 2008 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 6.19 | 2,000 | 12,380 | 65,254 |
Sep 02 2008 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 6.20 | 1,500 | 9,300 | 63,754 |
Sep 02 2008 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 6.18 | 2,000 | 12,360 | 61,754 |
Sep 02 2008 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 6.13 | 2,500 | 15,325 | 59,254 |
Sep 02 2008 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 6.12 | 2,000 | 12,240 | 57,254 |
Mar 05 2008 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 6.99 | 35,000 | 244,650 | 35,000 |
Feb 15 2008 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 0.00 | 700 | 0 | 66,544 |
Jul 26 2007 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 0.00 | 1,200 | 0 | 67,039 |
Feb 27 2007 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 13.50 | 35,000 | 472,500 | 35,000 |
Aug 01 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Buy | 0.60 | 5,000 | 3,000 | 74,214 |
Aug 01 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 10.42 | 5,000 | 52,100 | 69,214 |
Aug 01 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Sell | 10.55 | 2,500 | 26,375 | 66,714 |
Aug 01 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 0.60 | 5,000 | 3,000 | 0 |
Apr 04 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Buy | 3.75 | 625 | 2,344 | 68,622 |
Jan 24 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Buy | 0.00 | 15,000 | 0 | 67,997 |
Jan 24 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | 16.80 | 40,000 | 672,000 | 40,000 |
Jan 03 2006 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | CFO & CAO | Buy | 3.75 | 320 | 1,200 | 52,997 |
Dec 07 2005 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance & CAO | Sell | 0.00 | 200 | 0 | 52,677 |
Oct 03 2005 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance & CAO | Buy | 3.75 | 223 | 836 | 52,877 |
Jul 01 2005 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance & CAO | Buy | 3.75 | 140 | 525 | 52,654 |
Apr 01 2005 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance & CAO | Buy | 3.75 | 367 | 1,376 | 52,514 |
Jan 18 2005 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance & CAO | Option Exercise | 6.16 | 30,000 | 184,800 | 30,000 |
Jan 04 2005 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance & CAO | Buy | 3.75 | 127 | 476 | 52,147 |
Oct 04 2004 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance & CAO | Buy | 3.66 | 150 | 549 | 52,020 |
Jul 02 2004 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance | Buy | 4.64 | 103 | 478 | 51,870 |
Apr 02 2004 | ARNA | ARENA PHARMACEUTICALS INC | HOFFMAN ROBERT | VP, Finance | Buy | 5.45 | 108 | 589 | 51,767 |